|
|
Volumn 56, Issue 1-2, 2001, Pages 13-19
|
|
The continuing evolution of the drug discovery process in the pharmaceutical industry
|
|
Author keywords
Discovery; Disease; Drivers; Drug; Evolution; Human; Process; Technology
|
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ASPERLICIN;
BENZODIAZEPINE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BURIMAMIDE;
CARDIAC GLYCOSIDE;
CHLORDIAZEPOXIDE;
CHOLECYSTOKININ RECEPTOR BLOCKING AGENT;
CIMETIDINE;
DIAZEPAM;
DIGITALIS;
HISTAMINE H2 RECEPTOR ANTAGONIST;
MEPROBAMATE;
NEUROPEPTIDE;
COMPREHENSION;
CONFERENCE PAPER;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG SCREENING;
DRUG SYNTHESIS;
ECONOMICS;
EVOLUTION;
FUTUROLOGY;
GENETICS;
HUMAN;
NONHUMAN;
PREDICTION;
TECHNOLOGY;
DRUG INDUSTRY;
|
|
EID: 0035271614
PISSN: 0014827X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-827X(01)01019-9 Document Type: Conference Paper |
|
Times cited : (25)
|
|
References (8)
|
